WHA Committees Approve Plans On Antimicrobial Resistance, Vaccines, Innovation 25/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Today, member states in committee at the World Health Assembly adopted the first global plan of action to address the issue of antimicrobial resistance, and a global plan of action on vaccines. In addition, a mechanism on public health, innovation and intellectual property was postponed until 2022, and a deadline for its evaluation moved to 2018.
WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable 25/05/2015 by William New, Intellectual Property Watch 1 Comment The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.
Review Of WHO Mechanism To Fight Substandard Medicines Postponed Until 2017 22/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment World Health Organization delegates today agreed in committee to postpone until 2017 the review of a mechanism that had been set up to help countries deal with substandard and fake medicines.
WHO Debates Plan To Fight Antibiotic Resistance 22/05/2015 by Eimear Murphy for Intellectual Property Watch 2 Comments World Health Organization members this week are debating a plan to address the global problem of increasing resistance to existing antibiotics and the lack of new treatments to replace them. Today, discussions on antimicrobial resistance went to informals to try to resolve outstanding issues.
At WIPO, 11 Members Sign New Act Protecting GIs, More To Follow 21/05/2015 by Catherine Saez, Intellectual Property Watch 3 Comments Today, the signing ceremony of the new World Intellectual Property Organization agreement to protect geographical indications was held. On the first day, 11 members, mostly current Lisbon members, signed the Geneva Act of the Lisbon Agreement for the Protection of Appellations of Origin and Geographical Indications.
Lisbon Members Near Completion Of New Act On Geographical Indications 20/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment [Update: the new Act has been adopted. More to come.] After a week of drafting, a handful of World Intellectual Property Organization members – with often divergent input from other WIPO members – are close to concluding a new international agreement on the protection of geographical indications.
World Health Assembly Opens: Time Of Change At WHO; G-7 Involved 18/05/2015 by William New, Intellectual Property Watch 2 Comments “The Ebola outbreak shook this organization to its core,” World Health Organization Director General Margaret Chan said in opening the WHO’s annual assembly today. And the need to better construct the world’s emergency response systems has the biggest economies on the podium, with German Chancellor Angela Merkel speaking as chair of the Group of 7.
Drafting Exercise For WIPO Delegates As Lisbon Members Advance On New Act of Treaty 15/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Members of a World Intellectual Property Organization-managed treaty protecting appellations of origin this week are working to add geographical indications to the treaty. They are addressing issues not yet agreed upon, including the sustainability of the system, and how to address prior use of such geographical indications by trademark owners.
US Ponders New Trademark Rights For Racial Slurs 14/05/2015 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Some words are too offensive to be registered trademarks. Racial slurs, derogatory names for ethnic groups, and other terms that disparage people can be denied registration, according to the vast majority of countries. The US, however, might soon back away from this anti-bigotry stance. The nation’s courts may be on the verge of ruling that the registration of derogatory terms is protected by the Constitution’s guarantee of free speech.
In ‘Huge’ Move, WHO Adds Key Hepatitis C, Cancer, TB Drugs To Essential Medicines List 08/05/2015 by William New, Intellectual Property Watch 2 Comments The World Health Organization today published its updated Model List of Essential Medicines, including high-priced new treatments for hepatitis C, cancers and multi-drug resistant tuberculosis (MDR-TB) that were quickly applauded by the public health advocacy community.